EFFLIGREX Trademark
Trademark Overview
On Monday, August 18, 2003, a trademark application was filed for EFFLIGREX with the United States Patent and Trademark Office. The USPTO has given the EFFLIGREX trademark a serial number of 78288485. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2012. This trademark is owned by Novartis AG. The EFFLIGREX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, antibacterials, antivirals, antibiotics, and antifungals
General Information
Serial Number | 78288485 |
Word Mark | EFFLIGREX |
Filing Date | Monday, August 18, 2003 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, September 28, 2012 |
Registration Number | 2985002 |
Registration Date | Tuesday, August 16, 2005 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 24, 2005 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, antibacterials, antivirals, antibiotics, and antifungals |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, September 28, 2012 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Novartis AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Basel CH |
Party Name | Novartis AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Basel CH |
Party Name | Novartis AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Basel CH |
Trademark Events
Event Date | Event Description |
Friday, September 28, 2012 | CANCELLED SEC. 8 (6-YR) |
Saturday, June 27, 2009 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Saturday, June 27, 2009 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, August 16, 2005 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, May 24, 2005 | PUBLISHED FOR OPPOSITION |
Wednesday, May 4, 2005 | NOTICE OF PUBLICATION |
Tuesday, February 1, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, January 21, 2005 | ASSIGNED TO LIE |
Tuesday, January 18, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, January 14, 2005 | AMENDMENT FROM APPLICANT ENTERED |
Wednesday, December 29, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, December 29, 2004 | PAPER RECEIVED |
Thursday, January 6, 2005 | AMENDMENT FROM APPLICANT ENTERED |
Monday, December 6, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Sunday, December 19, 2004 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, December 6, 2004 | PAPER RECEIVED |
Thursday, August 12, 2004 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Thursday, February 26, 2004 | LETTER OF SUSPENSION E-MAILED |
Thursday, February 26, 2004 | ASSIGNED TO EXAMINER |